4//SEC Filing
Furey John 4
Accession 0001609351-18-000030
CIK 0001609351other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:52 PM ET
Size
8.6 KB
Accession
0001609351-18-000030
Insider Transaction Report
Form 4
Furey John
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-04-12$77.51/sh−20,000$1,550,200→ 0 total - Exercise/Conversion
Common Stock
2018-04-12$49.74/sh+20,000$994,800→ 20,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2018-04-12−20,000→ 140,000 totalExercise: $49.74Exp: 2026-11-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $77.56, inclusive. The reporting person undertakes to provide to Spark Therapeutics, Inc., any security holder of Spark Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]25% vests December 1, 2017 and the remainder vests in equal quarterly installments over the following three years following December 1, 2017.
Documents
Issuer
Spark Therapeutics, Inc.
CIK 0001609351
Entity typeother
Related Parties
1- filerCIK 0001691218
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 5:52 PM ET
- Size
- 8.6 KB